Isoliquiritigenin Ameliorates Ischemia-Induced Myocardial Injury via Modulating the Nrf2/HO-1 Pathway in Mice
DOI: https://doi.org/10.2147/DDDT.S362754
2022-04-30
Abstract:Deshan Yao, 1, 2 Bo Shi, 3 Sichuan Wang, 1, 2 Liuxiang Bao, 1, 2 Meng Tan, 1, 2 Hui Shen, 1, 2 Zhengang Zhang, 1, 2 Xin Pan, 1, 2 Yi Yang, 1, 2 Yong Wu, 1, 2 Kaizheng Gong 1, 2 1 Department of Cardiology, the Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225001, People's Republic of China; 2 Jiangsu Key Laboratory of Integrative Medicine for the Control of Geriatrics and Institute of Cardiovascular Disease, Yangzhou University, Yangzhou, 225001, People's Republic of China; 3 School of Life Science, Liaoning Normal University, Dalian, 116081, People's Republic of China Correspondence: Kaizheng Gong; Yong Wu, Department of Cardiology, the Affiliated Hospital of Yangzhou University, Yangzhou University, No. 368 Hanjiang Middle Road, Yangzhou, 225001, People's Republic of China, Tel +86-514-82981199, Email ; Background: Oxidative stress and inflammatory reaction play critical roles in acute myocardial infarction (AMI). Isoliquiritigenin (ISL), a flavonoid monomer extracted from licorice, has been found to have antioxidant and anti-inflammatory effects in cancer studies. Here, we tested the effect and underlying mechanisms of ISL on ischemia-induced myocardial injury in a mouse AMI model. Methods: Adult C57BL/6 mice were pre-treated by intraperitoneal injection of ISL and/or a specific nuclear factor E2-related factor 2 (Nrf2) inhibitor ML385 for 3 days, respectively. Then, the AMI model was established by ligating the anterior descending branch of the left coronary artery. Myocardial oxidative stress status, inflammatory response, cardiac function and infarction size were assessed after 7th day of surgery. Results: Compared with sham group, the reactive oxygen species (ROS) and malondialdehyde (MDA) level in AMI group were significantly increased. However, the superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) level were dramatically decreased. ISL treatment significantly reduced the myocardial infarction area, improved cardiac function, inhibited the production of ROS and MDA and reduced the consumption of SOD and GSH-Px. Interestingly, ISL could significantly increase nuclear Nrf2 and cytosolic heme oxygenase 1 (HO-1) level in the infarcted myocardium and reduce the oxidative stress after AMI. Also, ISL treatment dramatically inhibited the activation of myocardial NF-κB pathway and reduced the expression of pro-inflammatory factors in the AMI group. However, the administration of ML385 not only suppressed the Nrf2/HO-1 activation, the anti-oxidant and anti-inflammatory effects induced by ISL, but also attenuated the beneficial role of ISL on reducing infarct size and improving cardiac function in the mouse with AMI. Conclusion: The results suggested that activation of Nrf2/HO-1 pathway has an essential role in ISL-induced cardiac protection by alleviating myocardial oxidative stress and inflammation response in mice with AMI. Keywords: isoliquiritigenin, acute myocardial infarction, oxidative stress, Nrf2, NF-κB The pathogenesis of AMI is complex and involves overproduction of reactive oxygen species (ROS), DNA damage, apoptosis, calcium overload, necrosis, mitochondrial dysfunction, and inflammatory responses. 1,2 It is well known that the excessive accumulation of ROS disrupts the balance between oxidation and antioxidant system and induced oxidative stress. 2–4 The increased production of free radicals formed in the process of oxidative stress can trigger lipid peroxidation and protein oxidation to an inactive state, thereby resulting in protein dysfunction, apoptosis, autophagy, mitochondrial dysfunction, endoplasmic reticulum stress, extracellular matrix deposition, and inflammatory reaction. 1,5–7 Recently, accumulating evidences has shown that oxidative stress is the leading cause of the poor outcome of ischemic myocardial injury in AMI; 8,9 it is an important promoter of myocardial cell death and a decline in systolic and diastolic function. 10 Besides, ROS can act as second messengers to activate stress-related nuclear transcription factors in cardiomyocytes through mitogen-activated protein kinase (MAPK), Src family of tyrosine protein kinases, and cytokines, thereby leading to cell hypertrophy and apoptosis. 11 Nuclear factor E2-related factor 2 (Nrf2) is an important transcription factor for cellular activation of defense against oxidative stress. When oxidative stress damage occurs, Nrf2 enters the nucleus and activates the expression of downstream target molecules such as he -Abstract Truncated-